A Nottingham company which has devised a blood test that could revolutionise management of tuberculosis has raised a further £2.4 million to further develop the test and support clinical trials. The funding for PBD Biotech has come from a consortium led by fund managers Mercia and Foresight Group, both investing from the Midlands Engine Investment … Continue reading BioTech company devises ‘breakthrough’ TB blood test